The Pink Tax: Gender-Based Cost Disparities of Topical Minoxidil

July 2025 in “ International Journal of Women’s Dermatology ”

Michael M Ong, Anisah Alladeen, Nadia Khan, Rita Ohan, Shari R. Lipner

minoxidil topical minoxidil androgenetic alopecia 2% minoxidil 5% minoxidil pink tax Rogaine

Studysummary This study found that the "pink tax" persists in topical minoxidil products, with foams marketed to women costing about 20% more than those for men, despite identical ingredients and an overall price increase since 2017. Our plain-language summary of this paper — not a Tressless recommendation.

The study highlights the persistent "pink tax" in topical minoxidil products, with foams marketed to women being 20% more expensive than those for men, despite identical ingredients. Women are primarily offered the less effective 2% minoxidil, while men receive the more effective 5% concentration. This price disparity contributes to financial inequities and may hinder treatment access for women with androgenetic alopecia, which significantly impacts quality of life. The study analyzed 25 retailers, finding that women's foams cost an average of $30.43/60 mL compared to men's at $25.31/60 mL. The authors suggest dermatologists recommend 5% minoxidil for women due to its better efficacy and lower cost. Addressing these disparities is crucial for equitable healthcare access.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Gender-Related Cost Discrepancies in a Cohort of 110 Facial Moisturizers

3 citations , April 2019 in “Journal of Cosmetic Dermatology”

This study reported that facial moisturizers marketed to women were significantly more expensive than similar products marketed to men, with an average difference of $3.09 per ounce.

research Association Between Gender and Drug Cost for Over-the-Counter Minoxidil

8 citations , June 2017 in “JAMA Dermatology”

Women pay more for the same 5% minoxidil foam than men, but prices for liquid solutions are similar.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations , March 2004 in “Journal of The American Academy of Dermatology”

In this 48-week trial, 5% topical minoxidil was more effective than both 2% minoxidil and placebo in promoting hair growth in women with female pattern hair loss, with notable improvements in nonvellus hair count and hair growth assessments.